What Ovarian Reserve Really Means
Ovarian reserve is, roughly, how many eggs remain in the ovaries. A person is born with one to two million resting follicles; by puberty that pool is down to roughly 300,000 to 500,000, and across a reproductive lifetime only about 400 to 500 eggs are actually ovulated. The rest are lost through a continuous process of natural attrition that accelerates somewhat after the mid-thirties. Reserve testing estimates the size of that remaining pool—a quantity, not a measure of how healthy or chromosomally normal those eggs are.
That distinction between quantity and quality is the single most useful idea in this whole topic. Age remains the strongest available proxy for egg quality, while AMH and related tests estimate how many eggs might respond in a stimulation cycle. Knowing the number helps a clinician plan: how urgently to act, how a cycle is likely to respond, and which treatment gives the best return on the time available. It does not tell anyone whether they can become a parent.
What AMH Measures, and Why It Is Convenient
Anti-Müllerian hormone, or AMH, is produced by the granulosa cells of small growing follicles. Because those small follicles reflect the size of the resting pool, their hormone output correlates reasonably well with the number of eggs remaining. AMH has two practical advantages: it fluctuates little across the menstrual cycle, so it can be drawn on any day, and it is not masked by a high estradiol the way FSH can be. A typical reference range in common use is about 1.0 to 4.0 ng/mL; a value below roughly 1.0 suggests diminished reserve, while higher values are often seen in PCOS.
One common source of confusion is units. Some laboratories report ng/mL and others pmol/L; multiplying ng/mL by about 7.14 converts to pmol/L. A number that looks alarming in one unit may be unremarkable in the other, and assays differ between laboratories, so results should always be read against the reference range on the report you were given rather than against a chart found online.
AMH Levels by Age: A Realistic Table
The following are population-level ranges commonly seen in clinical practice, not diagnostic thresholds. They illustrate the downward trend with age; they do not predict any individual’s outcome.
| Age | Commonly seen AMH range (ng/mL) | How to read it |
|---|---|---|
| Under 35 | Roughly 2.0 to 4.0 | Usually a comfortable response to stimulation |
| 35 to 37 | Roughly 1.5 to 3.0 | Declining, but often still a workable yield per cycle |
| 38 to 40 | Roughly 1.0 to 2.0 | Fewer eggs per cycle; quality becomes the larger concern |
| Over 40 | Often below 1.0 | Low yield expected; age-related quality dominates outcomes |
Two patients of the same age can have very different AMH values and similar outcomes, and two patients with the same AMH can have quite different outcomes because age and diagnosis differ. The trend is useful for planning; the single number is not a verdict.
AMH, AFC, and FSH: What Each Test Adds
AMH is rarely interpreted alone. An antral follicle count (AFC) is the number of small resting follicles visible on a transvaginal ultrasound, best performed in the early follicular phase, around cycle days 2 to 5; roughly 10 to 20 across both ovaries is commonly considered normal. A day-3 hormone panel, drawn on cycle days 2 to 4, adds FSH and estradiol: an FSH above about 10 IU/L can suggest reduced reserve, and estradiol is checked alongside it because a high estradiol can suppress FSH and make it look deceptively normal. Thyroid function and prolactin can be checked at any time, and a mid-luteal progesterone drawn about seven days before the expected period confirms whether ovulation actually happened.
When these tests disagree—which they sometimes do—a clinician weighs them together with age and history rather than picking a favorite. AMH and AFC say most about expected egg yield in a stimulation cycle; FSH adds context about the hormonal feedback loop; none of them measures quality. Our fertility FAQs guide explains what each test in a first evaluation is for.
What AMH Cannot Tell You
This is worth stating plainly, because a single number causes a great deal of unnecessary anxiety. AMH does not measure egg quality or chromosome normality. It does not tell you whether you can conceive without assistance—many people with low AMH conceive spontaneously, and some people with reassuring AMH struggle for other reasons. It does not provide a countdown to menopause or a reliable answer to “how many years do I have.” It does not guarantee IVF success or failure, because live birth depends more on age and embryo factors than on the hormone level itself. And a low result is not a reason to conclude that treatment is pointless.
What AMH is genuinely good at is predicting how many eggs a stimulation cycle is likely to produce. That makes it a planning tool for medication dosing and for setting expectations about egg or embryo yield—useful, but much narrower than the meaning people often attach to it.
Low AMH: What It Means for Your Plan
Fewer eggs remaining means a shorter runway, not a closed door. The eggs that are present may still be healthy, particularly in younger patients, which is why low reserve and good outcomes can coexist. In practice, a low AMH changes the plan in four concrete ways: act sooner rather than later; avoid spending many months on treatments with low per-cycle odds; consider IVF earlier rather than committing to a long series of IUI cycles; and plan for cumulative attempts rather than expecting one cycle to settle everything. If reserve is very low, or if prior cycles produced only a few eggs, donor eggs offer high success rates and are a well-established path worth an honest conversation.
How those treatment choices compare on cost, burden, and per-cycle success is laid out in our IUI vs IVF comparison. The guiding idea is to match the plan to the time available rather than to a number in isolation.
High AMH: The PCOS and IVF Context
A high AMH is not automatically good news. In polycystic ovary syndrome, AMH commonly runs two to three times higher than usual because many small follicles are present; that reflects the condition’s disrupted follicle development, not a larger or better supply of eggs. Our PCOS and fertility guide explains that distinction in detail. In an IVF setting, a high AMH also predicts a strong response to stimulation medication, which raises the risk of ovarian hyperstimulation syndrome. Clinics respond with lower starting doses, closer monitoring, and often a freeze-all strategy rather than transferring in the same cycle. A high number changes how treatment is managed; it does not mean the outcome is secured.
When to Test, and How Often
AMH can be drawn on any day of the cycle, which is why it is often added to a visit already scheduled for something else. AFC and the FSH/estradiol panel do need specific timing, days 2 to 5 and days 2 to 4 respectively. Repeating AMH every few weeks adds little: the value moves slowly, and short-term fluctuation is more likely to reflect assay variation than a real biological change. Retesting after several months, or after an event that could affect reserve such as ovarian surgery or chemotherapy, is more informative.
Context matters as much as timing. Reserve testing belongs in a full evaluation that also checks the tubes, the uterine cavity, and the partner’s sperm parameters—male factors contribute to roughly 40 percent of infertility, and our male infertility guide covers that side of the workup. Evaluating both partners at once prevents months of investigating one person while an untreated factor sits on the other side.
Fertility Preservation and AMH
AMH and AFC are also the starting point for anyone considering fertility preservation, because they help estimate how many eggs a single stimulation cycle might yield. That estimate matters: for someone under 35, roughly 15 to 20 mature eggs is a common target for a reasonable chance of one live birth from those eggs, and older patients generally need more, so reaching the target may take more than one cycle. Our egg freezing guide walks through the process, the age effect, and how to think about the numbers. The practical implication of the AMH trend is simple: preservation works better when the pool is larger and the eggs are younger.
Questions Patients Ask Most
Can supplements or lifestyle changes raise AMH?
No intervention reliably increases the number of eggs remaining. Vitamin D deficiency is sometimes corrected for general health, and supplements are often marketed for “egg quality,” but the evidence that any of them meaningfully changes AMH is weak. What lifestyle changes do improve is the environment in which treatment happens—smoking cessation, a healthy weight, adequate sleep, and avoiding unnecessary delays all support outcomes without pretending to replenish a finite pool.
Can I conceive naturally with low AMH?
Yes, it happens regularly. Low reserve limits how many eggs are available in a given cycle, but ovulation can still occur and the egg released can still be healthy. The reasonable response is to shorten the runway—seek evaluation earlier, confirm that other factors are fine, and set a clear point at which to move to treatment—rather than to assume conception is impossible.
Should I repeat the test to watch for changes?
Occasionally, but not frequently. A decline over months or years is expected; a change between two tests weeks apart is usually noise. Repeating is most useful when a result would change a decision—before starting a stimulation cycle, or after surgery or medical treatment that could affect the ovaries. Otherwise, spend the effort on the plan rather than on re-measuring.
Key Takeaways
- Ovarian reserve estimates egg quantity; age remains the best available proxy for egg quality.
- AMH can be drawn on any cycle day; a typical reference range is about 1.0 to 4.0 ng/mL, and units matter (1 ng/mL is about 7.14 pmol/L).
- Age-specific ranges describe population trends, not individual verdicts; laboratory assays differ.
- AMH is read alongside antral follicle count and a day-2-to-4 FSH/estradiol panel, never in isolation.
- AMH cannot measure egg quality, predict natural conception, or give a reliable fertility countdown.
- Low AMH calls for acting sooner and considering IVF earlier—not for assuming pregnancy is impossible.
- High AMH is common in PCOS and predicts a strong stimulation response, so IVF protocols are adjusted to keep OHSS risk low.
- Testing both partners together and using the numbers to shape a timeline is more useful than repeating a single value.
Taking the Next Step
A test result is a starting point for a conversation, not a conclusion. If you have an AMH value in hand, a consultation can place it alongside your age, your cycle history, your ultrasound findings, and your timeline—and turn those four things into a plan. For the full picture of what a first evaluation involves, including when in the cycle each test is done, see our fertility FAQs guide.